適時開示情報
- 2025/09/05
- Approval for Marketing Authorization for Efinaconazole in Germany for the Treatment of Onychomycosis
- 2025/09/02
- Approval for Marketing Authorization for ECCLOCK gel 5% in Korea for Treatment of Primary Axillary Hyperhidrosis
- 2025/08/07
- Strategic Collaboration with Astria Therapeutics, Inc. to Develop and Commercialize Navenibart for Hereditary Angioedema in Japan
TD-net(適時開示情報閲覧サービス)にて開示された情報を掲載しております。